KIMBERLY BUCK: Open Payments
NPI 1891002929 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 16 payments from 9 companies in 2025. Trend: 2023 $551 · 2024 $660 · 2025 $324
Food & beverage: $324
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 3 | $68 |
| Exact Sciences Corporation | 3 | $62 |
| Lilly USA, LLC | 2 | $38 |
| Novo Nordisk Inc | 2 | $38 |
| ABBVIE INC. | 2 | $35 |
| Azurity Pharmaceuticals, Inc. | 1 | $28 |
| Abbott Laboratories | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: APRETUDE, Cologuard Collection Kit, MOUNJARO, QULIPTA, TRIPTODUR, FREESTYLE LIBRE 3, Ozempic, SHINGRIX.
Industry payments across MO — which companies pay providers there.
